Response to McGirr et al.'s Comment on “Clinical and Economic Impact of a Potential Switch from 13-Valent to 10-Valent Pneumococcal Conjugate Infant Vaccination in Canada”

被引：0
|
作者：
Michele R. Wilson
Matt Wasserman
Taj Jadavji
Maarten Postma
Marie-Claude Breton
Francois Peloquin
Stephanie R. Earnshaw
Cheryl McDade
Heather L. Sings
Raymond Farkouh
机构：
[1] RTI Health Solutions,Departments of Pediatrics, Microbiology, Immunology, and Infectious Diseases, Faculty of Medicine, Cumming School of Medicine
[2] Pfizer Inc.,Department of Pharmacy
[3] University of Calgary,Research Institute of Science in Healthy Aging and healthcaRE (SHARE)
[4] University of Groningen,undefined
[5] University of Groningen,undefined
[6] University Medical Center Groningen (UMCG),undefined
[7] Pfizer Canada Inc.,undefined
[8] Pfizer Inc.,undefined
来源：
Infectious Diseases and Therapy | 2018年 / 7卷
关键词：
Cost-effectiveness; Health economics; Pneumococcal disease; Vaccination;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：539 / 543
页数：4
相关论文
共 50 条
  • [21] Estimating the Public Health and Economic Impact of Introducing the 13-Valent Pneumococcal Conjugate Vaccine or 10-Valent Pneumococcal Conjugate Vaccines into State Immunization Programs in India
    Ghia, Canna J.
    Horn, Emily K.
    Rambhad, Gautam
    Perdrizet, Johnna
    Chitale, Ramaa
    Wasserman, Matt D.
    INFECTIOUS DISEASES AND THERAPY, 2021, 10 (04) : 2271 - 2288
  • [22] Cost-effectiveness of conjugate pneumococcal vaccination in Singapore: Comparing estimates for 7-valent, 10-valent, and 13-valent vaccines
    Tyo, Karen Richards
    Rosen, Melissa M.
    Zeng, Wu
    Yap, Mabel
    Pwee, Keng Ho
    Ang, Li Wei
    Shepard, Donald S.
    VACCINE, 2011, 29 (38) : 6686 - 6694
  • [23] Response to article by Johnna Perdrizet et al.,"Cost-effectiveness analysis of replacing the 10-valent pneumococcal conjugate vaccine (PCV10) with the 13-valent pneumococcal conjugate vaccine (PCV13) in Brazil infants"
    Gomez, Jorge A.
    Pinto, Thatiana de Jesus Pereira
    Guevara, Javier Nieto
    Noronha, Tatiana Guimaraes de
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (01)
  • [24] Re-Analysis of Modeling a Switch from a 13-Valent to 10-Valent Pneumococcal Conjugate Vaccine in Canada: Leveraging Real-World Experience from Belgium
    Wasserman, Matt D.
    Sings, Heather L.
    Wilson, Michele R.
    Postma, Maarten J.
    Breton, Marie-Claude
    McDade, Cheryl
    Farkouh, Raymond A.
    INFECTIOUS DISEASES AND THERAPY, 2019, 8 (01) : 1 - 3
  • [25] Re-Analysis of Modeling a Switch from a 13-Valent to 10-Valent Pneumococcal Conjugate Vaccine in Canada: Leveraging Real-World Experience from Belgium
    Matt D. Wasserman
    Heather L. Sings
    Michele R. Wilson
    Maarten J. Postma
    Marie-Claude Breton
    Cheryl McDade
    Raymond A. Farkouh
    Infectious Diseases and Therapy, 2019, 8 : 1 - 3
  • [26] Correction to: Estimating the Public Health and Economic Impact of Introducing the 13-Valent Pneumococcal Conjugate Vaccine or 10-Valent Pneumococcal Conjugate Vaccines into State Immunization Programs in India
    Canna J. Ghia
    Emily K. Horn
    Gautam Rambhad
    Johnna Perdrizet
    Ramaa Chitale
    Matt D. Wasserman
    Infectious Diseases and Therapy, 2021, 10 : 2289 - 2289
  • [27] COST-EFFECTIVENESS OF 13-VALENT VERSUS 10-VALENT PNEUMOCOCCAL CONJUGATE VACCINE USE IN CROATIA NATIONAL VACCINATION PROGRAM
    Tichopad, A.
    Pecen, L.
    Roberts, C. S.
    Uglesic, L.
    Tesovic, G.
    Rogier, K.
    VALUE IN HEALTH, 2014, 17 (07) : A608 - A608
  • [28] ECONOMIC IMPACT OF A 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINATION PROGRAMME IN A MEXICAN CORPORATE SETTING
    Huicochea-Bartelt, J. L.
    Mucino-Ortega, E.
    Vargas-Valencia, J. J.
    VALUE IN HEALTH, 2014, 17 (03) : A277 - A277
  • [29] Reply to Farkouh RA et al. Comment on "CostEffectiveness Evaluation of the 10-Valent Pneumococcal Non-Typeable Haemophilus Influenzae Protein D Conjugate Vaccine and 13-Valent Pneumococcal Vaccine in Japanese Children''
    Shiragami, Makoto
    Mizukami, Akiko
    Leeuwenkamp, Oscar
    Mrkvan, Tomas
    Delgleize, Emmanuelle
    Kurono, Yuichi
    Iwata, Satoshi
    INFECTIOUS DISEASES AND THERAPY, 2015, 4 (02) : 235 - 244
  • [30] The impact of 10-valent and 13-valent pneumococcal conjugate vaccines on hospitalization for pneumonia in children: A systematic review and meta-analysis
    Alicino, Cristiano
    Paganino, Chiara
    Orsi, Andrea
    Astengo, Matteo
    Trucchi, Cecilia
    Icardi, Giancarlo
    Ansaldi, Filippo
    VACCINE, 2017, 35 (43) : 5776 - 5785
12345